Duration of infectious viral shedding in patients with mild to moderate COVID-19 treated with REGN-CoV2()

INTRODUCTION: New treatment methods, such as REGN-CoV2, have been approved for patients with coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the effect of the drug on the duration of infectious viral shedding and viral mutations is unkn...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomura, Toshihito, Kitagawa, Hiroki, Kakimoto, Masaki, Kaiki, Yuki, Nazmul, Tanuza, Miyamori, Daisuke, Omori, Keitaro, Shigemoto, Norifumi, Ito, Masanori, Sakaguchi, Takemasa, Ohge, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938179/
https://www.ncbi.nlm.nih.gov/pubmed/35370078
http://dx.doi.org/10.1016/j.jiac.2022.03.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938179/
https://www.ncbi.nlm.nih.gov/pubmed/35370078
http://dx.doi.org/10.1016/j.jiac.2022.03.013

Ejemplares similares